Professor Amanj Kurdi
Strathclyde Institute of Pharmacy and Biomedical Sciences
Personal statement
Personal statement
Professor Kurdi is a Professor of Pharmacoepidemiology and Pharmacy Practice. He specialises in Pharmacoepidemiology and Drug Utilisation Research, especially concerning cardiovascular diseases, diabetes, and antibiotics. This includes studying medication adherence and persistence through the analysis of secondary databases and patient-level data, utilising a range of statistical and analytical methods.
Additionally, Professor Kurdi is keen on exploring Health Service Research and the evaluation of health policies and clinical guidelines' effects. Open to both national and international collaborations with fellow researchers and academics, Dr. Kurdi actively participates in events and conferences like EuroDURG and ICPE, fostering a collaborative environment for advancing research in these areas.
Back to staff profile
Prize And Awards
- Honorary Professor
- Recipient
- 1/6/2026
- External Examiner
- Recipient
- 24/2/2025
- Top-ranked research paper in the Seventh Excellent Paper Symposium (1st Position)
- Recipient
- 16/11/2024
- Honorary Reader in Pharmacoepidemiology and Pharmacy Practice, NHS Lanarkshire, Scotland.
- Recipient
- 1/3/2024
- Best Researcher (Poster winner)
- Recipient
- 11/2/2024
- Reproducibility Recognition by HDR UK as a member of EAVE II – Early Pandemic Evaluation and Enhanced Surveillance of COVID-19
- Recipient
- 31/1/2024
Back to staff profile
Publications
- Tocilizumab versus sarilumab among adults hospitalised with COVID-19 : target trial emulation across England and Scotland
- Zheng Bang, Kurdi Amanj, Amstutz Alain, Green Amelia, Herrett Emily, Tazare John, Wen Qing, Mahalingasivam Viyaasan, Smith Rebecca, MacKenna Brian, Mehrkar Amir, Bacon Sebastian, Goldacre Ben, Robertson Chris, Sheikh Aziz, Tomlinson Laurie
- Nature Communications (2026)
- https://doi.org/10.1038/s41467-026-73134-9
- Budget impact analysis of the introduction of ranibizumab's biosimilar to the Jordanian joint procurement system
- Hamida Jalal Abu, Alkhatib Nimer S, Hammour Khawla Abu, Halloush Shiraz, Kurdi Amanj, Balkhi Bander, Alfayez Osamah M, Mousa Rimal
- Frontiers in Public Health Vol 14 (2026)
- https://doi.org/10.3389/fpubh.2026.1800784
- Opioid utilisation and their associated mortality in Northern Ireland
- Kurdi Amanj
- The 42nd ICPE Annual Meeting (2026)
- Antibiotic shortages among public sector hospitals across Sub-Saharan Africa : findings and implications from a pilot study
- Munzhedzi Mukhethwa, Meyer Johanna, Chigome Audrey, Miljković Nenad, Moore Catrin E, Kumar Gauri, Kurdi Amanj, Campbell Stephen M, Godman Brian
- Advances in Human Biology (2026)
- Evolution of economic evidence use in drug pricing decisions in Jordan : using a standardized pharmacoeconomic checklist to inform value-based decisions
- Mousa Rimal, Hammad Eman, Melhem Samar, Balkhi Bander, Kurdi Amanj, Massad Eman
- Health Policy and Technology Vol 15 (2026)
- https://doi.org/10.1016/j.hlpt.2026.101222
- The Scottish Medicines in Pregnancy programme : supporting the surveillance of medicines use during pregnancy and assessment of associated clinical outcomes
- Mueller Tanja, Stobo Laura, Jarvis Lynne, Millar Morven, Moore Emily, Hopkins Leanne, Stark Victoria, Hynd Amy, Osei-Oppong Kwaku, Kurdi Amanj, McTaggart Stuart, Wood Rachael, Bennie Marion
- European Journal of Clinical Pharmacology Vol 82 (2026)
- https://doi.org/10.1007/s00228-026-04062-2
Back to staff profile
Professional Activities
- Cross-Faculty Connections: Growing Networks and Building Opportunities with and for Children and Young People
- Participant
- 26/2/2026
- Cross-Faculty Connections: Growing Networks and Building Opportunities with and for Children and Young People
- Participant
- 26/2/2026
- Invited Guest Speaker at the 15th International Congress of Pharmaceutical Sciences (CIFARP 2025)around Real-world evidence
- Speaker
- 29/10/2025
- CPD course: Alkitab university pharmacy students summer school
- Organiser
- 7/7/2025
- NORDIC Social Pharmacy Conference 2025
- Organiser
- 4/6/2025
- External Examiner for the “Professional Certificate in Pharmacoepidemiology & Pharmacovigilance” course at London School of Hygiene and Tropical Medicine
- Examiner
- 24/2/2025
Projects
- Enhancing Real-World Data Analysis Skills through Transnational Education: Bridging Global Health Knowledge and Practical Applications
- Kurdi, Amanj (Principal Investigator)
- 01-Jan-2026 - 31-Jan-2027
- Tackling antimicrobial resistance in Saudi Arabia: a multidisciplinary program to instigating evidence-based, theory-driven antimicrobial stewardship interventions using mixed-method approach
- Elrggal, Mahmoud (CoPI) Kurdi, Amanj (Principal Investigator)
- A 48 months project funded by The Saudi Basic Science Initiative, Research Development and Innovation Authority (RDIA), ~£300K
- 01-Jan-2025 - 30-Jan-2029
- Real world effectiveness of Tirzepatide, Semaglutide, and Liraglutide effects on Lipid Profile, Blood Pressure, body weight, HbA1c and heart rate among diabetic and non-diabetic patients: A Systematic Review and meta-analysis of Observational Studies
- Alotaibi, Eman (Principal Investigator) Kurdi, Amanj (Principal Investigator) Alotaibi, Badriah (Academic)
- 01-Jan-2024 - 30-Jan-2025
- Cancer Medicines Outcomes Programme - Public Health Scotland
- Dunlop, Emma (Co-investigator) Mueller, Tanja (Co-investigator) Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Lu, Liya (Researcher) Kavanagh, Kimberley (Co-investigator)
- The aim of CMOP-PHS is to better understand the real world outcomes of cancer medicines for cancer patients in Scotland. The project is a collaboration between the University of Strathclyde, Public Health Scotland and the NHS Health Boards.
- 01-Jan-2024 - 31-Jan-2027
- Prescribing medicines use in pregnancy: A scoping review protocol
- Parvin, Mst Irin (Principal Investigator) Mueller, Tanja (Principal Investigator) Kurdi, Amanj (Principal Investigator)
- Medication use during pregnancy can have detrimental effects on the mother as well as the unborn child, which might be unknown. Studies on medicine use during pregnancy can provide valuable information about the medications that pregnant women most frequently use for the diseases they are prescribed and whether or or not using these medications could be harmful for the mother and/or the unborn child. Findings from this scoping review will provide an insight of the medicines used during pregnancy as well as a comprehensive summary of the current evidence on this topic.
- 10-Jan-2024 - 14-Jan-2024
- Profiling and assessing medicines use in pregnancy in Scotland: a population-based, whole system prescribing approach using routine data from clinical care
- Mueller, Tanja (Principal Investigator) Kurdi, Amanj (Co-investigator)
- 01-Jan-2023 - 30-Jan-2027
Back to staff profile
Contact
Professor
Amanj
Kurdi
Strathclyde Institute of Pharmacy and Biomedical Sciences
Email: amanj.baker@strath.ac.uk
Tel: 548 2181